Format
Sort by
Items per page

Send to

Choose Destination

Best matches for antihypertensive agents AND heart failure:

Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice. Corrao G et al. Hypertension. (2015)

Mineralocorticoid Receptor Antagonists for Treatment of Hypertension and Heart Failure. Sica DA et al. Methodist Debakey Cardiovasc J. (2015)

Heart failure in African Americans: disparities can be overcome. Sharma A et al. Cleve Clin J Med. (2014)

Search results

Items: 1 to 20 of 13254

1.

Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.

Sandip C, Yangchen SL, Amir S, Rezza JKS, Hisatomi A.

J Cardiovasc Pharmacol Ther. 2018 Jan 1:1074248418771341. doi: 10.1177/1074248418771341. [Epub ahead of print]

PMID:
29739234
2.

First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.

Wang G, Chen Y, Li L, Tang W, Wright JM.

J Hum Hypertens. 2018 May 1. doi: 10.1038/s41371-018-0066-x. [Epub ahead of print]

PMID:
29713053
3.

Hypertension in patients with type 2 diabetes mellitus: Targets and management.

Pavlou DI, Paschou SΑ, Anagnostis P, Spartalis M, Spartalis E, Vryonidou A, Tentolouris N, Siasos G.

Maturitas. 2018 Jun;112:71-77. doi: 10.1016/j.maturitas.2018.03.013. Epub 2018 Mar 30. Review.

PMID:
29704920
4.

[Which place for thiazide and thiazide-like diuretics in patients with type 2 diabetes ?]

Scheen AJ, Krzesinski JM.

Rev Med Liege. 2018 Apr;73(4):176-182. French.

PMID:
29676870
5.

Hypertension and Aortic Stenosis, a Review.

Rassa A, Zahr F.

Curr Hypertens Rev. 2018 Apr 16. doi: 10.2174/1573402114666180416161326. [Epub ahead of print]

PMID:
29658439
6.

β-Blockers in Myocardial Infarction: Issues With Standard Admission Order Sets.

Gupta A, Das SR, Pandey A.

JAMA. 2018 Mar 27;319(12):1269-1270. doi: 10.1001/jama.2018.0845. No abstract available.

PMID:
29584845
7.

Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.

Schroeder EB, Chonchol M, Shetterly SM, Powers JD, Adams JL, Schmittdiel JA, Nichols GA, O'Connor PJ, Steiner JF.

Clin J Am Soc Nephrol. 2018 May 7;13(5):727-734. doi: 10.2215/CJN.09510817. Epub 2018 Mar 23.

PMID:
29572286
8.

The safety of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension: Protocol for a systemic review and network meta-analysis.

Gu ZC, Zhang YJ, Pan MM, Zhang C, Liu XY, Wei AH, Su YJ.

Medicine (Baltimore). 2018 Mar;97(11):e0122. doi: 10.1097/MD.0000000000010122. Review.

9.

Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery.

Duncan D, Sankar A, Beattie WS, Wijeysundera DN.

Cochrane Database Syst Rev. 2018 Mar 6;3:CD004126. doi: 10.1002/14651858.CD004126.pub3. Review.

PMID:
29509957
10.

Implications of the New National Guidelines for Hypertension.

Aronow WS, Frishman WH.

Cardiol Rev. 2018 Mar/Apr;26(2):55-61. doi: 10.1097/CRD.0000000000000187.

PMID:
29419560
11.

Type 2 Diabetes and Thiazide Diuretics.

Scheen AJ.

Curr Diab Rep. 2018 Feb 5;18(2):6. doi: 10.1007/s11892-018-0976-6. Review.

PMID:
29399724
12.

Aggressive systolic blood pressure control in older subjects: benefits and risks.

Chrysant SG.

Postgrad Med. 2018 Mar;130(2):159-165. doi: 10.1080/00325481.2018.1433434. Epub 2018 Feb 1. Review.

PMID:
29375010
13.

[Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].

Liu Q, Zhang C, Li QQ, Zhu Y, Zhang D, Zhao WG, Gu H.

Zhonghua Er Ke Za Zhi. 2018 Jan 2;56(1):23-28. doi: 10.3760/cma.j.issn.0578-1310.2018.01.007. Chinese.

PMID:
29342993
14.

Serum Hepatocyte Growth Factor Is Probably Associated With 3-Month Prognosis of Acute Ischemic Stroke.

Zhu Z, Xu T, Guo D, Huangfu X, Zhong C, Yang J, Wang A, Chen CS, Peng Y, Xu T, Wang J, Sun Y, Peng H, Li Q, Ju Z, Geng D, Chen J, Zhang Y, He J.

Stroke. 2018 Feb;49(2):377-383. doi: 10.1161/STROKEAHA.117.019476. Epub 2018 Jan 10.

PMID:
29321335
15.

Selective ß1-Blockers Are Not Associated With New-onset Diabetes Mellitus in Hypertensive Patients.

Park Y, Choi BG, Rha SW, Baek MJ, Ryu YG, Choi SY, Byun JK, Shim MS, Mashaly A, Li H, Jang WY, Kim W, Kang JH, Choi JY, Park EJ, Park SH, Lee S, Na JO, Choi CU, Lim HE, Kim EJ, Park CG, Seo HS, Oh DJ.

J Cardiovasc Pharmacol. 2018 Jan;71(1):38-45. doi: 10.1097/FJC.0000000000000543.

PMID:
29286954
16.

Sacubitril and valsartan fixed combination to reduce heart failure events in post-acute myocardial infarction patients.

Zaid Iskandar M, Lang CC.

Drugs Today (Barc). 2017 Oct;53(10):545-551. doi: 10.1358/dot.2017.53.10.2722396. Review.

PMID:
29286056
17.

The Divergent Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Adult Patients With Type 2 Diabetes Mellitus.

Strauss MH, Hall AS.

Can J Diabetes. 2018 Apr;42(2):124-129. doi: 10.1016/j.jcjd.2017.09.011. Epub 2017 Dec 22.

PMID:
29277343
18.

Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines.

Ramos IC, Versteegh MM, de Boer RA, Koenders JMA, Linssen GCM, Meeder JG, Rutten-van Mölken MPMH.

Value Health. 2017 Dec;20(10):1260-1269. doi: 10.1016/j.jval.2017.05.013. Epub 2017 Jun 20.

PMID:
29241885
19.
20.

Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity.

Wallentin F, Wettermark B, Kahan T.

J Clin Hypertens (Greenwich). 2018 Jan;20(1):106-114. doi: 10.1111/jch.13149. Epub 2017 Dec 8.

Supplemental Content

Loading ...
Support Center